EndoStim

EndoStim is a medical device company focused on the treatment of gastroesophageal reflux disease (GERD) through electrical stimulation of the lower esophageal sphincter. GERD is a condition affects millions of people worldwide and is often not optimally treated despite a maximum drug dosage of medications such as proton pump inhibitors (PPIs). EndoStim’s innovative technology provides a solution addressing the root physiological cause of the disease — namely a weak or dysfunctional lower esophageal sphincter that allows for reflux into the esophagus.

Company’s Keywords:

biotechnology, life sciences